KRAS and familial pancreatic carcinoma: In addition, high 1CM activity has been linked to increased tumor aggressiveness and reduced prognosis in several cancer entities, and a dependency of MTHFD2 on KRAS and its prognostic impact was described in AC, colorectal, and pancreatic cancer [18,19,46].